RIKEN Genesis and Mitsui Knowledgy Industry will offer sequencing service for cancer personalized treatment from July 2017

The service is based on RIKEN Genesis OncoPrime Basic test carried out at RIKEN Genesis Innovation Genome Center in Kawasaki and will first be limited to four national university hospitals (Tokyo University, Okayama University, Hokkaido University and Chiba University), to be eventually extended to 10 university hospitals. RIKEN Genesis is an affiliate company of Sysmex Corporation.

Mitsui Knowledge Industry news release, June 20, 2017

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny